Atlas Venture Fund Vii L P - Net Worth and Insider Trading

Atlas Venture Fund Vii L P Net Worth

The estimated net worth of Atlas Venture Fund Vii L P is at least $4,437 dollars as of 2024-11-13. Atlas Venture Fund Vii L P is the 10% Owner of ARCA biopharma Inc and owns about 174 shares of ARCA biopharma Inc (ABIO) stock worth over $4,437. Details can be seen in Atlas Venture Fund Vii L P's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Atlas Venture Fund Vii L P has not made any transactions after 2012-10-25 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Atlas Venture Fund Vii L P

To

Atlas Venture Fund Vii L P Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Atlas Venture Fund Vii L P owns 4 companies in total, including Larimar Therapeutics Inc (LRMR) , Viridian Therapeutics Inc (VRDN) , and Egalet Corp (EGLTQ) among others .

Click here to see the complete history of Atlas Venture Fund Vii L P’s form 4 insider trades.

Insider Ownership Summary of Atlas Venture Fund Vii L P

Ticker Comapny Transaction Date Type of Owner
LRMR Larimar Therapeutics Inc 2015-03-24 10 percent owner
VRDN Viridian Therapeutics Inc 2017-02-13 10 percent owner
EGLTQ Egalet Corp 2014-02-11 10 percent owner
LIMIT LIMIT 2012-10-25 10 percent owner

Atlas Venture Fund Vii L P Latest Holdings Summary

Atlas Venture Fund Vii L P currently owns a total of 1 stock. Atlas Venture Fund Vii L P owns 174 shares of ARCA biopharma Inc (ABIO) as of October 25, 2012, with a value of $4,437.

Latest Holdings of Atlas Venture Fund Vii L P

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ABIO ARCA biopharma Inc 2012-10-25 174 25.50 4,437

Holding Weightings of Atlas Venture Fund Vii L P


Atlas Venture Fund Vii L P Form 4 Trading Tracker

According to the SEC Form 4 filings, Atlas Venture Fund Vii L P has made a total of 0 transactions in ARCA biopharma Inc (ABIO) over the past 5 years. The most-recent trade in ARCA biopharma Inc is the sale of 0 shares on October 25, 2012, which brought Atlas Venture Fund Vii L P around $0.

Insider Trading History of Atlas Venture Fund Vii L P

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Atlas Venture Fund Vii L P Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Atlas Venture Fund Vii L P Ownership Network

Ownership Network List of Atlas Venture Fund Vii L P

No Data

Ownership Network Relation of Atlas Venture Fund Vii L P

Insider Network Chart

Atlas Venture Fund Vii L P Owned Company Details

What does Larimar Therapeutics Inc do?

Who are the key executives at Larimar Therapeutics Inc?

Atlas Venture Fund Vii L P is the 10 percent owner of Larimar Therapeutics Inc. Other key executives at Larimar Therapeutics Inc include 10 percent owner & other: Possible Member of 10% Group James E Flynn , Chief Development Officer Gopi Shankar , and Chief Medical Officer Russell Clayton .

Larimar Therapeutics Inc (LRMR) Insider Trades Summary

Over the past 18 months, Atlas Venture Fund Vii L P made no insider transaction in Larimar Therapeutics Inc (LRMR). Other recent insider transactions involving Larimar Therapeutics Inc (LRMR) include a net purchase of 4,290,617 shares made by James E Flynn , a net purchase of 57,208 shares made by Thomas Edward Hamilton , and a net purchase of 5,000 shares made by Michael Celano .

In summary, during the past 3 months, insiders sold 0 shares of Larimar Therapeutics Inc (LRMR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Larimar Therapeutics Inc (LRMR) were sold and 4,367,575 shares were bought by its insiders, resulting in a net purchase of 4,367,575 shares.

Larimar Therapeutics Inc (LRMR)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Larimar Therapeutics Inc Insider Transactions

No Available Data

Atlas Venture Fund Vii L P Mailing Address

Above is the net worth, insider trading, and ownership report for Atlas Venture Fund Vii L P. You might contact Atlas Venture Fund Vii L P via mailing address: 56 Wareham Street, Floor 3, Boston Ma 02118.